NCT03961100 - A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 6, 2019

Primary Completion Date

August 9, 2019

Study Completion Date

August 9, 2019

Conditions

Solid Tumor

Interventions

DRUG

Entrectinib 600 mg (T1)

Test formulation 1 (T1): Multi-particulate formulation 1: entrectinib film-coated mini-tablets

DRUG

Entrectinib 600 mg (T2)

Test formulation 2 (T2): Multi-particulate formulation 2: entrectinib film-coated mini-tablets

DRUG

Entrectinib 200 mg (R)

Reference formulation (R): entrectinib hard capsules

DRUG

Entrectinib 200 mg (T)

Test formulation (T): entrectinib HPMC capsules

Trial Locations (1)

Quotient Clinical Ltd, Clinical Research Unit, Nottingham